BeOne Medicines
ONC
#652
Rank
โ‚ฌ30.65 B
Marketcap
276,98ย โ‚ฌ
Share price
-2.56%
Change (1 day)
40.95%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

BeOne Medicines (ONC) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : โ‚ฌ3.00 Billion

According to BeOne Medicines's latest financial reports the company's total liabilities are โ‚ฌ3.00 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

BeOne Medicines - Total liabilities on balance sheet (from 2014 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31โ‚ฌ2.48 B21.26%
2023-12-31โ‚ฌ2.05 B10.26%
2022-12-31โ‚ฌ1.86 B-12.31%
2021-12-31โ‚ฌ2.12 B50.72%
2020-12-31โ‚ฌ1.40 B148.76%
2019-12-31โ‚ฌ0.56 B30.51%
2018-12-31โ‚ฌ0.43 B43.62%
2017-12-31โ‚ฌ0.30 B500.24%
2016-12-31โ‚ฌ50.29 M29.57%
2015-12-31โ‚ฌ38.81 M69.51%
2014-12-31โ‚ฌ22.9 M-37.4%
2013-12-31โ‚ฌ36.58 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Onconova Therapeutics
ONTX
โ‚ฌ10.42 M-99.65%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
โ‚ฌ0.59 B-80.30%๐Ÿ‡บ๐Ÿ‡ธ USA